Efficacy of aliskiren/hydrochlorothiazide single-pill combinations in aliskiren non-responders.

Georg Nickenig, Vladimir Simanenkov, Giuseppe Lembo, Pablo Rodriguez, Thomas Salko, Shannon Ritter, Jack Zhang

Research output: Contribution to journalArticle

Abstract

OBJECTIVES: To evaluate the efficacy, safety and tolerability of a single-pill combination of the direct renin inhibitor aliskiren and hydrochlorothiazide (HCT) in patients with hypertension and an inadequate BP response to aliskiren monotherapy (mean sitting diastolic BP [msDBP] > 90 and <or = 110 mmHg following 4 weeks of aliskiren 300 mg). METHODS: In this study, 880 patients with hypertension and an inadequate BP response to aliskiren monotherapy were randomized to once-daily, double-blind treatment with a single-pill combination of aliskiren/HCT 300/25 mg or 300/12.5 mg, or aliskiren 300 mg monotherapy. At the week 8 endpoint, least-squares mean changes in mean sitting systolic/diastolic BP (msSBP/DBP) from baseline were analyzed for the intent-to-treat population. RESULTS: Aliskiren/HCT 300/25 mg and 300/12.5 mg provided significantly greater msSBP/DBP reductions from baseline (15.9/11.0 mmHg and 13.5/10.5 mmHg, respectively) than aliskiren 300 mg alone (8.0/7.4 mmHg; both p

Original languageEnglish
Pages (from-to)31-40
Number of pages10
JournalBlood Pressure, Supplement
Volume2
Publication statusPublished - Dec 2008

Fingerprint

Hydrochlorothiazide
Hypertension
aliskiren
Least-Squares Analysis
Renin
Safety

ASJC Scopus subject areas

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Nickenig, G., Simanenkov, V., Lembo, G., Rodriguez, P., Salko, T., Ritter, S., & Zhang, J. (2008). Efficacy of aliskiren/hydrochlorothiazide single-pill combinations in aliskiren non-responders. Blood Pressure, Supplement, 2, 31-40.

Efficacy of aliskiren/hydrochlorothiazide single-pill combinations in aliskiren non-responders. / Nickenig, Georg; Simanenkov, Vladimir; Lembo, Giuseppe; Rodriguez, Pablo; Salko, Thomas; Ritter, Shannon; Zhang, Jack.

In: Blood Pressure, Supplement, Vol. 2, 12.2008, p. 31-40.

Research output: Contribution to journalArticle

Nickenig, G, Simanenkov, V, Lembo, G, Rodriguez, P, Salko, T, Ritter, S & Zhang, J 2008, 'Efficacy of aliskiren/hydrochlorothiazide single-pill combinations in aliskiren non-responders.', Blood Pressure, Supplement, vol. 2, pp. 31-40.
Nickenig, Georg ; Simanenkov, Vladimir ; Lembo, Giuseppe ; Rodriguez, Pablo ; Salko, Thomas ; Ritter, Shannon ; Zhang, Jack. / Efficacy of aliskiren/hydrochlorothiazide single-pill combinations in aliskiren non-responders. In: Blood Pressure, Supplement. 2008 ; Vol. 2. pp. 31-40.
@article{2a185169a61e4a658c5b8667d3765dbf,
title = "Efficacy of aliskiren/hydrochlorothiazide single-pill combinations in aliskiren non-responders.",
abstract = "OBJECTIVES: To evaluate the efficacy, safety and tolerability of a single-pill combination of the direct renin inhibitor aliskiren and hydrochlorothiazide (HCT) in patients with hypertension and an inadequate BP response to aliskiren monotherapy (mean sitting diastolic BP [msDBP] > 90 and",
author = "Georg Nickenig and Vladimir Simanenkov and Giuseppe Lembo and Pablo Rodriguez and Thomas Salko and Shannon Ritter and Jack Zhang",
year = "2008",
month = "12",
language = "English",
volume = "2",
pages = "31--40",
journal = "Blood Pressure, Supplement",
issn = "0803-8023",
publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - Efficacy of aliskiren/hydrochlorothiazide single-pill combinations in aliskiren non-responders.

AU - Nickenig, Georg

AU - Simanenkov, Vladimir

AU - Lembo, Giuseppe

AU - Rodriguez, Pablo

AU - Salko, Thomas

AU - Ritter, Shannon

AU - Zhang, Jack

PY - 2008/12

Y1 - 2008/12

N2 - OBJECTIVES: To evaluate the efficacy, safety and tolerability of a single-pill combination of the direct renin inhibitor aliskiren and hydrochlorothiazide (HCT) in patients with hypertension and an inadequate BP response to aliskiren monotherapy (mean sitting diastolic BP [msDBP] > 90 and

AB - OBJECTIVES: To evaluate the efficacy, safety and tolerability of a single-pill combination of the direct renin inhibitor aliskiren and hydrochlorothiazide (HCT) in patients with hypertension and an inadequate BP response to aliskiren monotherapy (mean sitting diastolic BP [msDBP] > 90 and

UR - http://www.scopus.com/inward/record.url?scp=57949113028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57949113028&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 31

EP - 40

JO - Blood Pressure, Supplement

JF - Blood Pressure, Supplement

SN - 0803-8023

ER -